We are very serious researchers. #AUA24 #GoBlue

🤩🤩 it’s Alex Zhu on the main stage #AUA24 talking about an RCT he led in residency 💫

Important work by Ben Pockros highlighting how the inflation reduction act is directly saving patients thousands of dollars every year on medications. Policy is working! #AUA24

First time MUSIC Urology and hopefully not the last. So many important projects to learn from across the state

Thank you to all the trainees who participated in MUS presentation session on quality improvement projects at the Collaborative-wide Meeting on Friday. Congratulations Ben Pockros and Jen Thelus for winning first and second place in the competition! 🎉

Awesome weekend AcademyHealth learning about policy and HSR And nothing better than a crabcake Baltimore Orioles Park 👌🏻🦀⚾️

Online Tools to Decrease Out-of-Pocket Prescription Costs for Patients: A Practical Guide for Urologists read the full article here! 👉 bit.ly/4aSTaUg #AUA #Urology #AUAmembers

Most importantly for patients, out-of-pocket costs will be capped at $2,000 in 2025 for Medicare Part D More research to come on this soon 👀

One year later! Rebecca Howland sharing her incredible experience learning about NGB transition clinic Cleveland Clinic Urology UMN Urology

Favorite consult of residency so far

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for cancer patients prescribed oral chemotherapy, reports new study in JAMA Network Open: michmed.org/z4mkR Ben Pockros Kristian Stensland, MD MPH U-M IHPI

This economic evaluation found that the out-of-pocket cap legislated by the Inflation Reduction act may save patients enrolled in Medicare Part D plans a median of $7260 in 2024 for oral cancer medications. ja.ma/4ggHKOh

A new study finds efforts to cap prescription drug spending could save cancer patients more than $7,200 a year in out-of-pocket spending. Ben Pockros U-M IHPI JAMA Network Open Full paper: jamanetwork.com/journals/jaman… Summary: michmed.org/z4mkR